Co-treatment with additional antiplatelets, H2-receptor antagonists (H2RA), angiotensin II Type 1 receptor blockers, angiotensin-converting enzyme inhibitor, 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor, and NSAIDs was not associated with peptic ulcers (Table 2). The gene discussed is ACE; the disease is peptic ulcer disease.